FREDERICK, Md., Oct. 10, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced disposable electroceutical devices, announced that on Monday, October 3rd, 2016 it met with senior management from the FDA’s Division of Neurological and Physical Medicine Devices, including the Deputy Division Director, the Acting Branch Chief of the Physical Medicine and … Continue Reading
Reflexonic, LLC On September 9, 2016, we signed an Exclusive Licensing and Supply Agreement with Reflexonic, LLC. Reflexonic sells and distributes urological medical devices, products, and related medical products. Reflexonic will assist in the development of urological products for the treatment of overactive bladder, interstitial cystitis and bladder pain syndrome by providing device therapeutic specifications, … Continue Reading
FREDERICK, Md., Sept. 28, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced neuromodulation medical devices announced that it has submitted a paper: “ActiPatch© Central Sensitization Therapy: A Chronic Back Pain Registry Study of Pain Relief & Analgesic Adverse Effects” for publication. The study reports that the majority of chronic back pain sufferers have … Continue Reading
FREDERICK, Md., Sept.13, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Sweden distributor, Harmony Health, Sweden, AB , has received initial stocking orders for Pharmacy Heart,www.apotekhjartat.se and the Life health products chain, www.lifebutiken.se. Life health products are a chain of 220 stores and Pharmacy … Continue Reading
Pending FDA Market Clearance for Over-the-Counter Sales We had a second status meeting with the FDA on Wednesday, July 20, 2016. Senior Management from the Neurology and Physical Medicine Group, 4 examiners, the Head of the Physical Medicine, and the project statistician were present. The meeting went well and the tenor was very good. Our … Continue Reading
How is your chronic pain treated? If you feel your illness is misunderstood and you could use better or less costly treatments, sign this petition today asking the White House to implement the National Pain Strategy. The National Fibromyalgia & Chronic Pain Association (NFMCPA), with the Consumer Pain Advocacy Task Force (CPATF), recently launched a … Continue Reading
Pending U.S. FDA Market Clearance for Over-the-Counter Sales We had a second status meeting with the FDA on Wednesday, July 20, 2016. Senior Management from the Neurology and Physical Medicine Group, 4 examiners, the Head of the Physical Medicine, and the project statistician were present. The meeting went well and the tenor was very good. … Continue Reading
BioElectronics Expands Pulsed Shortwave Technology Thursday, July 7, 2016 Dr. Sree Koneru, our Director of Electroceutical Research working at the Clinical Science and Engineering Research Center, New York State University, Binghamton, New York, has made significant advances in our understanding and development of pulsed shortwave technology. A series of experiments using a unique testing device … Continue Reading
US FDA Meeting On May 24, 2016, we met with FDA reviewer for our ActiPatch device, key management from the Physical Medicine and Neurotherapeutic Devices Branch, senior leadership from the Division of Neurological and Physical Medicine Devices, and a Regulatory Advisor, Office of Device Evaluation. BioElectronics Attendees: Richard Staelin, PhD, Chairman of Board, PhD in … Continue Reading
FREDERICK, Md., May 11, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has engaged Adam Staelin as the Executive Vice President of Sales and Marketing. Mr. Staelin has 20 years of sales and marketing experience and has held major management roles at Teradata and Valassis. While at Teradata, a … Continue Reading